HomeCompareCRWRF vs NNN

CRWRF vs NNN: Dividend Comparison 2026

CRWRF yields 1.84% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NNN wins by $596.00 in total portfolio value· pulled ahead in Year 10
10 years
CRWRF
CRWRF
● Live price
1.84%
Share price
$24.20
Annual div
$0.44
5Y div CAGR
12%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.9K
Annual income
$702.06
Full CRWRF calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — CRWRF vs NNN

📍 NNN pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRWRFNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRWRF + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRWRF pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRWRF
Annual income on $10K today (after 15% tax)
$156.23/yr
After 10yr DRIP, annual income (after tax)
$596.75/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, NNN beats the other by $1,632.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRWRF + NNN for your $10,000?

CRWRF: 50%NNN: 50%
100% NNN50/50100% CRWRF
Portfolio after 10yr
$25.2K
Annual income
$1,662.37/yr
Blended yield
6.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

CRWRF
No analyst data
Altman Z
4.6
Piotroski
7/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRWRF buys
0
NNN buys
0
No recent congressional trades found for CRWRF or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRWRFNNN
Forward yield1.84%5.66%
Annual dividend / share$0.44$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR12%8.6%
Portfolio after 10y$24.9K$25.5K
Annual income after 10y$702.06$2,622.67
Total dividends collected$4.1K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CRWRF vs NNN ($10,000, DRIP)

YearCRWRF PortfolioCRWRF Income/yrNNN PortfolioNNN Income/yrGap
1$10,906$205.86$10,735$614.96+$171.00CRWRF
2$11,904$235.00$11,572$708.43+$332.00CRWRF
3$13,006$268.50$12,531$819.53+$475.00CRWRF
4$14,224$307.05$13,633$952.29+$591.00CRWRF
5$15,571$351.49$14,909$1,111.84+$662.00CRWRF
6$17,063$402.76$16,392$1,304.77+$671.00CRWRF
7$18,720$462.00$18,129$1,539.52+$591.00CRWRF
8$20,561$530.53$20,173$1,827.08+$388.00CRWRF
9$22,610$609.93$22,597$2,181.81+$13.00CRWRF
10← crossover$24,895$702.06$25,491$2,622.67$596.00NNN

CRWRF vs NNN: Complete Analysis 2026

CRWRFStock

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers InSight Denials to analyze, track, trend, and report on denial data; Trisus Healthcare Intelligence, a solution that provides insights into resource consumption on the patient level; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Sentrex 330; Referral Verification System; and Sentry Core, a solution that simplifies the complexities of pharmacy procurement, utilization, and compliances. Further, it offers appeal and professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Full CRWRF Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this CRWRF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRWRF vs SCHDCRWRF vs JEPICRWRF vs OCRWRF vs KOCRWRF vs MAINCRWRF vs ADCCRWRF vs EPRTCRWRF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.